Peptide compounds derived from melanotransferrin and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9334314
APP PUB NO 20150133385A1
SERIAL NO

14352600

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Peptide compounds derived from human melanotransferrin, and compositions thereof, are described. Uses of these peptide compounds, for example to modulate angiogenesis and/or cell migration, and/or to treat angiogenesis-related disorders (e.g., cancer), are also described.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THERATECHNOLOGIES INCQUEBEC CANADA QUEBEC

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Béliveau, Richard Ile-des-Soeurs, CA 15 109
Bousquet-Gagnon, Nathalie Mirabel, CA 8 29
Habi, Abdelkrim Pierrefonds, CA 17 209
Michaud-Levesque, Jonathan Montreal, CA 4 34
Peri, Krishna G Ville Saint-Laurent, CA 16 159

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 10, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00